Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CardioComm Solutions Inc. V.EKG

Alternate Symbol(s):  EKGGF

Healthcare Medical Devices
CardioComm Solutions, Inc. is a Canada-based company, which develops software, hardware and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. The Company's specialization is in the software engineering of computer based (ECG) management and reporting software. The software permits physician interpretations of ECGs and supports private and public payer fee-for-service billings. The Company’s device connectivity and ECG management technologies are used in medical, consumer, clinical research and telemedicine solutions for the recording, transmission, viewing, analyzing, reporting and storage of electrocardiograms, for arrhythmia screening, diagnosis, and management of cardiac patients. Its Global ECG Management Solutions (GEMS) and GlobalCardio (Cloud based GEMS) products are licensed worldwide to hospitals, ECG commercial reading services and physicians.


TSXV:EKG - Post by User

CardioComm Solutions Inc.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(4)
•••
Post by torpedoe21on Jun 09, 2021 7:33pm
217 Views
Post# 33359981

I sure hope we get apiece of this pie eventually

I sure hope we get apiece of this pie eventually
REDWOOD CITY, CA / ACCESSWIRE / May 4, 2021 /Biotricity, Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is pleased to announce that it's Biotres device is a finalist in Fast Company's 2021 World Changing Ideas. The World Changing Ideas Awards is a yearly award that honors businesses and projects that are committed to pursuing innovation to solve global issues

Biotricity, Inc. (BTCY)

Other OTC - Other OTC Delayed Price. Currency in USD
In watchlist
3.4300+0.1800 (+5.54%)
At close: 3:59PM EDT
 
Full screen
Trade prices are not sourced from all markets
Previous Close 3.2500
Open 3.4500
Bid N/A x N/A
Ask N/A x N/A
Day's Range 3.2800 - 3.7500
52 Week Range 0.6700 - 3.7500
Volume 277,547
Avg. Volume 79,648
Market Cap 131.978M
Beta (5Y Monthly) 2.00
PE Ratio (TTM) N/A
EPS (TTM) -0.4200
Earnings Date Feb. 11, 2021
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities